Uridine phosphorylase (UPh; EC 2.4.2.3) catalyzes the phosphorolytic cleavage of the N-glycosidic bond of uridine to form ribose 1-phosphate and uracil. This enzyme also activates pyrimidine-containing drugs, including 5-fluorouracil (5-FU). In order to better understand the mechanism of the enzyme-drug interaction, the complex of Salmonella typhimurium UPh with 5-FU was cocrystallized using the hanging-drop vapour-diffusion method at 294 K. X-ray diffraction data were collected to 2.2 Å resolution. Analysis of these data revealed that the crystal belonged to space group C2, with unit-cell parameters a = 158. 26, b = 93.04, c = 149.87 Å , = = 90, = 90.65 . The solvent content was 45.85% assuming the presence of six hexameric molecules of the complex in the unit cell.
Introduction
5-Fluorouracil (5-FU) has been used in chemotherapeutic regimens in patients with gastrointestinal malignancies, including oesophageal, gastric, colon and pancreatic tumours, as well as breast cancer for several decades (Kemeny, 1987; Huang et al., 2007) . This drug competes with uracil for interaction with thymidylate synthase. 5-FU interferes with DNA and RNA synthesis, thereby causing cell death. Furthermore, 5-halogen-containing derivatives of uracil are also used as antimicrobial agents. Synergism of 5-FU with antibacterial agents such as ceftriaxone, ceftazidime, cefotiam, piperacillin and netilmicin has been shown (Price et al., 1965; Gieringer et al., 1986; Yamashiro et al., 1986) . However, toxicity towards haematopoietic cells, skin, heart and neurons can limit the therapeutic efficacy of 5-FU and structurally similar drugs (Peters & van Groeningen, 1991) . Uridine phosphorylase (UPh) catalyzes the phosphorolytic cleavage of the N-glycosidic bond in uridine to produce ribose 1-phosphate and uracil (Leer et al., 1977; Vita et al., 1986) . This enzyme activates pyrimidine-based drugs, including 5-FU (Cao et al., 2002; CaradocDavies et al., 2004) . Therefore, studies of the structure of UPh bound to 5-FU should be instrumental in future modifications aimed at the design of 5-FU derivatives with lower general toxicity and retained antitumour and antimicrobial potencies (Iigo et al., 1990; Temmink et al., 2006; Matsusaka et al., 2007) .
Protein expression and purification
Salmonella typhimurium UPh (StUPh) was expressed in Escherichia coli and purified as reported elsewhere (Molchan et al., 1998; Dontsova et al., 2004) . The Escherichia coli BL21 (DE3) strain was transformed with the recombinant plasmid and grown on solid LB agar for 12 h at 310 K. Protein synthesis was stimulated with 0.5 mM isopropyl -d-1-thiogalactopyranoside. The biomass was sonicated, ammonium sulfate was added to precipitate the proteins and the pellets were dissolved in buffer (pH 7.2) containing 50 mM KH 2 PO 4 and 0.5 mM -mercaptoethanol. Further steps of StUPh purification were performed using chromatography on butyl Sepharose as a first step and Q-Sepharose as the final step. The enzymatic activity was 280 units per milligram of purified protein. The homogeneity of the purified StUph was 96% as determined by nondenaturing gel electrophoresis.
Crystallization of the StUph-5FU complex
Crystals of the complex of StUph with 5-FU (EBEWE Pharma, Austria) were obtained by cocrystallization (Fig. 1) . Crystallization was performed on siliconized glass slides (Hampton Research, USA) in Linbro plates at 294 K using the hanging-drop vapour-diffusion method. The reservoir solution (0.5 ml) consisted of 0.34 ml 0.1 M Tris-maleate-NaOH buffer pH 5.5 and 0.16 ml 40%(w/v) polyethylene glycol 3350. The crystallization drop contained 2 ml StUph solution (11.3 mg ml À1 ) in 10 mM Tris-HCl buffer pH 7.3, 2 ml H 2 O, 1.3 ml reservoir solution, 2 ml 100 mM 5-FU and 0.3 ml 2-propanol. Crystals of dimensions 0.07 Â 0.3 Â 0.5 mm were obtained after 1-2 weeks and were used for X-ray diffraction analysis.
X-ray analysis
The X-ray data set (Table 1 ) was collected upon irradiation of StUPh-5FU crystals under cryogenic conditions (100 K) on beamline 14.2 at BESSY, Berlin, Germany. The wavelength was 0.9184 Å . A CHESS CCD detector was used with an oscillation range Á' of 0.5 and a crystal-to-detector distance of 240 mm. Prior to freezing in liquid nitrogen, the crystals were transferred into cryoprotectant solution containing 100 mM Tris-maleate-NaOH buffer pH 5.5, 25%(w/v) polyethylene glycol 3350 and 20%(v/v) anhydrous glycerol. All data were processed and scaled using XDS (Kabsch, 1988) . 300 images were obtained during the collection of X-ray diffraction data. All data were indexed, merged and processed using the XDS program with XYCORR, INIT, COLSPOT, IDXREF, DEFPIX, XPLAN, INTEGRATE and CORRECT options. For a semiautomatic determination of the space group, the minimal value of the XDS 'quality of fit' function was used. The crystals of the StUPh-5-FU complex belonged to space group C2. Detailed data statistics are presented in Table 1 .
The structure was resolved by the molecular-replacement technique using the Phaser program with rigid-body refinement option (McCoy, 2007) . X-ray diffraction data from 10 to 2.5 Å resolution were used in this step. The X-ray structure of monomer A only of ligand-free StUPh at 1.76 Å resolution (Timofeev et al., 2007 ; PDB code 2oxf) was utilized as a search model. Water molecules were removed from the model. Six full homohexamer molecules were found in the unit cell. The Matthews coefficient (Matthews, 1968) was 2.27 Å 3 Da À1 and the solvent content was 45.85% (Table 1) . Only one solution was evident, with an R factor of 37.64% and a correlation coefficient R corr of 76.95%.
To improve the phase model, one macrocycle of simulated annealing using the phenix.refine module of PHENIX (Adams et al., 2002) was performed in the temperature range 12 000-300 K with 50 K steps and resolution 10-2.2 Å . Before refinement, 5% of the observations were chosen at random and set aside for cross-validation analysis and to monitor the various refinement strategies. Next Crystal of StUPh complexed with 5-FU. Figure 2
Preliminary structure of the uracil-binding site in the StUPh-5-FU complex.
Arg223 NH1-water (2.85 Å ), water-5-FU O4 (2.88 Å ), Arg168 NH1-5-FU O4 (3.00 Å ), Gln166 OE1-5-FU N3 (2.70 Å ), Gln166 NE2-5-FU O2 (2.89 Å ). Refinement of the structure is currently in progress and will be published elsewhere.
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